Edoxaban (Lixiana®)

Assessment Status Rapid review complete
Drug Edoxaban
Brand Lixiana®
Indication For the prevention of stroke/SE in adults with NVAF and for the treatment/secondary prevention of DVT and PE in adults.
Assessment Process
Rapid review commissioned 26/06/2015
Rapid review completed 10/07/2015
Rapid review outcome Full Pharmacoeconomic Evaluation Not Recommended